In April 2016, Astellas hosted its second annual Patient Advocacy Summit—entitled Changing Tomorrow Together: Partnering to Improve Patients’ Lives – in Washington D.C. A cornerstone of our evolving stakeholder engagement program in the Americas, the event brought together nearly 150 participants, including 105 patient advocates representing more than 90 groups from the U.S. and Canada. Attendees represented a wide range of therapeutic areas (including various forms of cancer, urologic health, kidney health, transplants, heart disease, infectious disease, arthritis and rare diseases), as well as advocates with a broader focus on R&D and access to quality care.
Issues addressed included the importance of reflecting patient priorities in the development of quality measures and value assessment frameworks, and “best practice” insights from patient advocacy leaders. Astellas leadership members also shared some of the many ways we strive to deliver value in the medicines we develop, the services we provide and our presence in the communities where we work and live.
The summit helps Astellas build and strengthen relationships with advocates who share a passion for improving and saving the lives of patients.
The day prior to the summit, Astellas also convened the inaugural meeting of a new Patient Advocates Advisory Committee. Comprised of approximately a dozen cross-therapeutic advocacy leaders, the committee serves as a resource for Astellas to better understand the priorities and collaborative opportunities within the patient community, and to gain feedback on Astellas’ efforts to best reflect patient’s engagement and voices throughout our business.